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V: Trigeminal nerve (fifth cranial nerve) 
V1: Ophthalmic (first) branch of the trigeminal nerve 
V2: Maxillary (second) branch of the trigeminal nerve 
V3: Mandibular (third) branch of the trigeminal nerve 
Vc: Trigeminal subnucleus caudalis 
VAS: Visual analogue scale 
WDR: Wide dynamic range 
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1. INTRODUCTION 
1.1. Background 
Pain is defined by the International Association for the Study of Pain (IASP) as “an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or described in terms of 
such damage (Merskey and Bogduk, 1994)”. 
Concerning an endogenous “pain inhibits pain” phenomenon, there is evidence that wide dynamic 
range (WDR) neurons (convergent neurons) are inhibited by nociceptive stimuli applied to areas of the body 
remote from the excitatory receptive fields (Le Bars, 2002). These phenomena are termed “diffuse noxious 
inhibitory controls (DNIC)” (Le Bars et al., 1979a,b). DNIC are triggered by the activities of most WDR and 
some nociceptive specific (NS) neurons in the spinal dorsal horn and trigeminal spinal tract nucleus, which 
are powerfully inhibited by stimulation of Aδ- and C-nociceptors in animals and humans (Le Bars, 2002). 
DNIC involve a supraspinal loop through the subnucleus reticularis dorsalis (SRD) in the medulla 
(Villanueva et al., 1988) and are observed in the intact but not in the spinal animal (Le Bars, 2002). It has 
recently been suggested that the DNIC-like effects in humans should be termed “Conditioned Pain 
Modulation (CPM)” (Yarnitsky et al., 2010). 
Though there are many reports of CPM in the spinal region (Price and McHaffie, 1988; Willer et al., 
1989; De Broucker et al., 1990; Le Bars et al., 1992), it has only been minimally investigated in the 
craniofacial region (Ellrich and Treede, 1998). 
Recently, a systematic model for inducing experimentally evoked tonic head pain has been developed 
(Sowman et al., 2011). The model is a mechanical craniofacial compressive device which produces pain 
similar to chronic tension-type headache (CTTH) and the device enables systematic testing of CPM in 
healthy subjects (Sowman et al., 2011). A pain model with repetitive electrical stimulation of the 
temporomandibular joint (TMJ) has also been developed (Ayesh et al., 2007). This method is reliable and 
allows the generation of a constant painful input to the TMJ without tissue damage. 
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There is a clear relationship between the intensity of the conditioning stimulus (CS) and the strength 
of the resultant CPM (Le Bars et al., 1992; Villanueva and Le Bars, 1995). However, it is unclear whether 
CPM effects in the craniofacial region are intensity dependent in human. 
DNIC, i.e. CPM, has initially been defined and tested with the CS applied to the extrasegmental 
region from the excitatory receptive fields (Le Bars et al., 1979a,b). Subsequently, the CPM effect with 
segmentally applied CS has been tested (Svensson et al., 1999a; Pud et al., 2005). Nevertheless, the 
interrelation between CPM effect and assessment sites has not yet been characterized. 
Some of the recent animal and human experimental studies have shown that there are significant 
gender differences in the CPM responses (Staud et al., 2003; Ge et al., 2004; Serrao et al., 2004). However, 
other studies have failed to detect it (France and Suchowiecki, 1999; Baad-Hansen et al., 2005; Pud et al., 
2005). The gender effect on the CPM is still unclear. 
Therefore, one of the aims of this project was to investigate systematically whether the CPM evoked 
by the tonic mechanical stimuli applied to the craniofacial region is intensity, assessment site (segmental: 
craniofacial region / extrasegmental: spinal region) and gender dependent (study I). 
There is growing evidence suggesting that CPM is attenuated in chronic pain patients suffering from 
temporomandibular disorders (TMD) (Maixner et al., 1995), fibromyalgia (Kosek and Hansson, 1997; 
Lautenbacher and Rollman, 1997), CTTH (Pielsticker et al., 2005), and migraine (Sandrini et al., 2006; 
Tommaso et al., 2007). Consideration of this fact has led us to propose the hypothesis that chronic 
craniofacial musculoskeletal pain conditions are associated with alterations in pain-modulatory processes 
reflected in CPM. 
To test this hypothesis it was planned to evaluate whether experimental craniofacial pain (painful 
electrical stimulation of the TMJ) conditions reflect disturbed CPM mechanisms and the influence of gender 
on such CPM effects in the craniofacial region (study II). 
The approximated median magnitude of the CPM effect is 29% (Pud et al., 2009). However, in this 
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report the data were derived from different test stimuli (TS) and CS applied to different assessment sites. 
Recent research (Yarnitsky et al., 2008) suggests that the evaluation of CPM may identify patients at risk of 
developing chronic pain. For further application of CPM as a diagnostic tool or for screening of analgesic 
compounds, the test-retest reliability and inter-individual variation in CPM should be determined. 
Hence, it was also evaluated if there are significant differences for the subjects (inter-individual and 
intra-individual dependent) in inducing the CPM responses with different stimulus modalities at several 
assessment sites (study III). 
The general hypotheses of the whole project are; 1) CPM evoked by tonic mechanical stimuli 
applied to the craniofacial region is intensity, assessment site and gender dependent, 2) experimental tonic 
craniofacial musculoskeletal pain triggers alterations in pain-modulatory processes, and 3) there are inter- 
and intra-individual variations in the CPM responses and this may vary with different techniques applied. 
 
1.2. The aims of our own investigation 
 To reach the above goals, three experimental studies were performed (See Fig. 1). 
The overall objectives of this project are: 
1. To test if CPM evoked by tonic mechanical stimuli applied to the craniofacial region is 
intensity, assessment site and gender dependent. 
2. To investigate the influence of experimental TMJ pain on CPM. 
3. To evaluate the magnitude of CPM, and the inter- and intra-individual variation in CPM with 
different stimulus modalities. 
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Figure 1. Diagram for experimental methodologies and aims in this project. 
Headband: mechanical craniofacial compressive device, PPT: pressure pain thresholds, PPTol: pressure pain 
tolerance thresholds, VAS: visual analogue scale, TA: tibialis anterior, VAS1.4: pain intensity assessed on a 
VAS following 1.4 x PPT applied to TA, VAS1.6: pain intensity assessed on a VAS following 1.6 x PPT 
applied to TA, TMJ: temporomandibular joint, CPM: conditioned pain modulation. Solid line: study I, square 
dotted line: study II, long dashed line: study III. 
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2. EXPERIMENTAL PAIN MODELS IN CRANIOFACIAL REGION 
2.1. Mechanical craniofacial pain 
2.1.1. Nociceptive mechanism of mechanical craniofacial pain 
 In general, primary headache disorders tend to involve predominantly the ophthalmic (first) branch 
of the trigeminal nerve (V1) along with its physiological overlap with the high cervical input by way of the 
trigeminocervical complex (Bartsch and Goadsby, 2005). However, many primary headache disorders also 
involve the face, in effect the maxillary (second, V2) and mandibular (third, V3) branches of the trigeminal 
nerve (fifth cranial nerve: V) (Goadsby et al., 2009). 
Cerebrovascular changes have been thought to be important for the initiation and maintenance of 
migraine and cluster-type headaches, although it is not clear that these changes play a significant role in 
tension-type headache (Moskowitz, 1990,1993; Connors, 1995; Strassman et al., 1996). Nevertheless, in all 
primary headaches, pain is perceived to come from within the cranium, and thus current theories suggest that 
activation of neural pathways that transmit input from the dura play an important role in headache (Strassman 
et al., 1996). 
The first link in this neural pathway is the activation of unmyelinated (C) or thinly myelinated (Aδ) 
dural afferent fibers. Many dural afferent fibers appear to be polymodal nociceptors as they respond to 
noxious mechanical, thermal, and chemical stimuli applied to their receptive fields (Dostrovsky et al., 1991; 
Strassman et al., 1996; Bove and Moskowitz, 1997; Strassman and Raymond, 1999; Levy and Strassman, 
2002a). The slowly adapting and graded response characteristics exhibited by dural afferent fibers to 
mechanical stimuli and the finding that they are commonly located in regions of the dura overlying 
meningeal blood vessels suggest that these fibers monitor information about cerebrovascular tone (Bove and 
Moskowitz, 1997; Levy and Strassman, 2002b). Mechanosensitivity in particular seems to be important in 
intracranial headaches as well as migraine (Levy and Strassman, 2002b). 
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2.1.2. Clinical craniofacial pain 
The headache disorders are classified in the second edition of the International Classification of 
Headache Disorders by the Headache Classification Committee of the International Headache Society 
(Headache Classification Committee of the International Headache Society, 2004). The headache disorders 
are classified as being either primary, where the headache syndrome is itself the problem, or secondary, 
where the headache syndrome is driven by other pathological processes. 
CTTH is a disorder evolving from episodic tension-type headache with daily or very frequent 
episodes of headache lasting minutes to days. The pain is typically bilateral, pressing or tightening in quality 
and of mild to moderate intensity, and it does not worsen with routine physical activity. There may be mild 
nausea, photophobia or phonophobia. Though the exact mechanisms of tension-type headache are not known, 
peripheral pain mechanisms are most likely to play a role in CTTH (Headache Classification Committee of 
the International Headache Society, 2004). Tension-type headaches, which are often associated with a feeling 
of muscle strain or spasm in the neck / shoulder or temporalis muscles and characterized by dull, aching, 
nonthrobbing pain that can be distributed unilaterally or bilaterally and referred to temporal, occipital, 
parietal, or frontal regions of the head, occur at a 50% higher rate in women (Taylor and Cleary 1989; 
Holroyd and Lipchik, 2000). 
 
2.1.3. Experimental mechanical craniofacial pain model 
 Mechanical and cold headbands have been developed and have shown that craniofacial pain evoked 
by a mechanical or thermal headband may induce widespread CPM responses in healthy humans (Wang et al., 
2010). The study was based on a compressive headband approach which had several limitations inherent in 
its mechanical design. These were mainly a result of the band design which limited the ability to direct and 
control forces. The irregular shape of the skull meant that pressure was applied unevenly around the skull and 
was directed primarily against prominent bony features. 
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Then the improved device, which can be fastened on the four probes (left, occiput, right, forehead, 
10 mm radius) around the skull with two centrally joined c-clamps offset from each other by 90 degrees, was 
developed (Sowman et al., 2011) (Fig. 2). A strain gauge force transducer is attached on the four probes and 
pressure can be adjusted over time using the visual analogue scale (VAS, 0-10 cm) feedback from the subject 
to maintain the pain intensity at a given level (target level). The tonic moderately-severe craniofacial pain 
triggered by this device was reported as dull, bilateral and like a strong headache similar to the quality of 
CTTH (Bigal and Lipton, 2005). The nociceptive input from the mechanical headband would be conducted 
via peripheral C-fibers including the temporalis muscle innervated by the mandibular branch of the 
trigeminal nerve (V3), the ventral part innervated by the ophthalmic branch of the trigeminal nerve (V1) and 
the dorsal part innervated by the second cervical nerve (C2). The device is a standardized mechanical tonic 
pain model for experimental evoking of tonic craniofacial pain and associated with robust CPM effects 
(Sowman et al., 2011). Therefore, we applied this device in studies I, II and III. 
- 15 - 
 
 
 
 
Figure 2. The compressive device for experimental craniofacial pain. 
The device was set on the vertex. It was height adjustable by a downwardly directed screw. Compression of 
the craniofacial region was achieved by tightening four horizontally opposed clamp screws with a force 
transducer. 
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2.2. Temporomandibular joint (TMJ) pain 
2.2.1. Nociceptive mechanism of TMJ pain 
 The temporomandibular joint (TMJ) and masticatory muscles are supplied by Aδ- and C-fiber 
polymodal nociceptive afferents that may respond to a wide range of peripheral stimuli, including mechanical 
(e.g., heavy pressure) and algesic chemical (such as glutamate, hypertonic saline, capsaicin, and mustard oil) 
stimuli in TMJ and around muscles (Sessle, 2005; Cairns, 2007,2010). A noxious stimulus activates 
nociceptive Aδ- and C-fibers, which project to the trigeminal subnucleus caudalis (Vc), site for a critical 
brainstem relay in the TMJ-jaw muscle reflex pathway (Tsai et al., 1999). Although there is evidence of TMJ 
afferent projections to the superficial laminae of Vc (Capra, 1987; Hathaway et al., 1995), most Vc neurons 
that respond to TMJ stimulation are found in laminae V and VI (Broton et al., 1988). These input may project 
to higher levels of the brain (e.g., in the thalamus) or in the brain stem region such as reticular formation 
(Sessle, 2005).    
 
2.2.2. Temporomandibular disorders (TMD) 
Temporomandibular disorders (TMD) comprise a number of problems involving the structures of 
and around the TMJ, the masticatory musculature, or both (De Leeuw, 2008). Pain is one of the most 
common complaints associated with TMD and can be clinically expressed as masticatory muscle pain or as 
TMJ arthralgia (as in synovitis, capsulitis or osteoarthritis) (Benoliel and Sharav, 2008). Pain may occur 
spontaneously or may be associated with joint function and loading (e.g., during chewing, yawing or biting). 
TMD may also include symptoms of dysfunction (limitation of movement, interference during movement, 
internal derangements of the TMJ or locking of the joint). TMD pain may be, but is not necessarily, 
associated with such a dysfunction (De Laat, 2010). 
Concerning diagnostic criteria of TMD, research diagnostic criteria (RDC-TMD) were established 
(Dworkin and LeResche, 1992) and translated into a clinical classification (Truelove et al., 1992). Three 
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subgroups (Myofascial pain (masticatory muscle pain); Anterior disc displacement; TMJ arthralgia, 
osteoarthritis and osteoarthrosis) have been distinguished and details can be accessed at the RDC-TMD 
website (http://www.rdc-tmdinternational.org). 
 
2.2.3. Experimental TMJ pain model 
When a cutaneous nerve is stimulated electrically, all three groups of cutaneous afferent fibers, i.e., 
Aβ-, Aδ- and C-fibers, are activated (Wagman and Price, 1969; Price and Wagman, 1970; Price et al., 1971; 
Gregor and Zimmermann, 1972; Menétrey et al., 1977), and the relative proportion of activation of individual 
fiber types depends on the stimulus intensity (Handwerker and Kobal, 1993). C-fibers have a higher 
activation threshold than Aδ-fibers. 
Our group has also developed an experimental craniofacial pain model with repetitive electrical 
stimulation of the TMJ (Ayesh et al., 2007). Two unipolar needle electrodes were inserted into TMJ (Fig. 3). 
Then the experimental craniofacial pain was induced by repetitive electrical stimulation (0.5 ms duration, 5 
Hz) to the TMJ to provide a constant painful input to the TMJ (Ayesh et al., 2007). This method is reliable 
and allows the generation of a constant painful input to the TMJ without tissue damage. 
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Figure 3. The experimental TMJ pain model. 
Two unipolar needle electrodes were inserted into the left TMJ. Then the experimental TMJ pain was induced 
by repetitive electrical stimulation (0.5 ms duration, 5 Hz) to the TMJ. 
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3. CONDITIONED PAIN MODULATION (CPM) 
Conditioned pain modulation (CPM) is the phenomenon through which the conditioning stimulus 
(CS) affects the test stimulus (TS) (Yarnitsky et al., 2010). This phenomenon reflects something that has been 
known in humans since ancient times, namely that one pain can mask another (Le Bars et al., 2001; Yarnitsky, 
2010). 
 
3.1. Methodological parameters 
3.1.1. Test stimulus (TS) 
To test CPM, various methodologies have been used (Pud et al., 2009) such as electrophysiological 
responses (e.g., somatosensory evoked brain potentials (Valeriani et al., 2005a,b; Oono et al., 2008), the 
spinal nociceptive flexion reflex (RIII reflex) (Willer et al., 1984; Serrao et al., 2004), blink reflex (Ellrich 
and Treede, 1998)) and pain thresholds (e.g., mechanical punctuate stimuli (Pud et al., 2005), pressure pain 
thresholds (Ge et al., 2004; Lautenbacher et al., 2008)). 
The pressure pain threshold (PPT) is the measurement for testing of deep pain sensitivity, which is 
probably mediated through Aδ- or C-fibers (Mense, 1993). Though pressure stimulation applied on the skin 
could reflect the pain sensitivity of both the superficial and deep structures, it was shown that the deep-tissue 
nociceptors mediate a major component of the pressure-induced pain during pressure algometry 
(Graven-Nielsen et al., 2004). 
Acute musculoskeletal pain is perceived to occur in response to stimulation of deep-tissue 
polymodal nociceptors related to Aδ- and C-afferent fibers (Mense, 1993), which can release sensitizing 
neuropeptides causing nociceptor sensitization and potentially hyperalgesia. Regarding specific mechanisms 
in musculoskeletal pain, additional information may be gained by quantitative sensory testing (QST) (Rolke 
et al., 2006) and quantitative assessment of pain. 
Manually applied pressure stimulation of nociceptors in deep tissue (hand-held pressure algometry, 
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Fig. 4) is a validated technique for the assessment of pain sensitivity and is widely used (Jensen et al., 1986; 
Chesterton et al., 2007). The variability associated with manually applied pressure stimulation may be 
minimized through the use of computer-controlled pressure stimulation (computer-controlled pressure 
algometry, Fig. 5), which also allows for the measurement of stimulus-response functions that relate the 
pressure intensity with the pain response (VAS) (Graven-Nielsen et al., 2004). In pressure algometry, the 
stimulation probe is typically 1 cm2 and the stimulated volume of tissue is relatively small. 
Pressure pain thresholds (PPT) and pressure pain tolerance thresholds (PPTol) tend to give large and 
robust CPM responses (Ge et al., 2004; Arendt-Nielsen et al., 2008; Wang et al., 2010), and hence they were 
used as TS in the present project. Pressure pain thresholds (PPT and PPTol) are recorded from the right 
masseter muscles (MAR) and left forearm (flexor carpi radialis muscle) by a hand-held pressure algometer 
(Somedic, Sweden) (Fig. 4) with a constant application rate of 30 kPa/s and an algometer probe with an area 
of 1 cm2 (Arendt-Nielsen et al., 2008) in studies I, II and III. 
In study III, PPT and PPTol obtained by a computer-controlled pressure algometer (Aalborg 
University, Denmark) (Fig. 5) were also used as TS and recorded from the right and left tibialis anterior (TA) 
with a constant application rate of 30 kPa/s and an algometer probe with an area of 1 cm2 (Graven-Nielsen et 
al., 2004). Additionally, the pain intensity which was assessed on a VAS (0-10 cm) following 1.4 and 1.6x 
PPT applied to TA (VAS1.4 and VAS1.6) was recorded to evaluate the reliability of TS modality. 
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Figure 4. Hand-held (manually applied) pressure algometer. 
 
 
 
 
Figure 5. Computer-controlled pressure algometer. 
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3.1.2. Conditioning stimulus (CS) 
To evoke the CPM effect in healthy humans, different laboratories apply different modalities of CS 
(Pud et al., 2009), such as thermal (cold (Arendt-Nielsen and Gotliebsen, 1992; Sandrini et al., 2006) and 
heat (Ellrich and Treede, 1998; Oono et al., 2008)), electrical (Motohashi and Umino, 2001), chemical 
(Valeriani et al., 2005a,b; Romaniello et al., 2002) and ischemic (Fujii et al., 2006). 
The standardized mechanical pain model for experimental evoking of tonic craniofacial pain (Fig. 2) 
is suitable for the CS in the craniofacial region and is associated with robust CPM effects (Sowman et al., 
2011). Therefore, this model was employed as CS and was applied with different target intensities (VAS0, 
VAS1, VAS3 and VAS5) in study I, and with an intensity above VAS5 in studies II and III (See 2.1.3. 
Experimental mechanical craniofacial pain model). The nociceptive input from the mechanical headband 
would be conducted via peripheral C-fibers. 
In order to evaluate the inter- and intra-individual variation in CPM, ischemic stimulation to the 
right upper arm and cold stimulation to the right hand were used as CS in addition to mechanical craniofacial 
pain in study III. 
The computer-controlled cuff algometry technique stimulates a larger volume of tissue. In cuff 
algometry, a tourniquet is inflated around an extremity and the pain response is measured on a VAS 
(Polianskis et al., 2001) (Fig. 6). In study III, ischemic muscle pain was induced by inflation of a 13 cm wide 
tourniquet applied around the right upper arm (innervated by C5-Th2) (VBM Medizintechnik GmbH, 
Germany). The lower rim of the tourniquet was 3 cm proximal to the cubital fossa. The cuff control unit 
(Aalborg University, Denmark) (Fig. 6) was programmed to maintain the pressure at 36 kPa (above the 
systolic pressure) throughout the inflation period. Ischemia predominantly activates C-fibers following 
arterial occlusion with an inflated tourniquet cuff and evokes pain because of tissue metabolic changes 
(decreased PO2, decreased glycemia, increased lactate and potassium levels, increased PCO2 and lowered 
pH) in the blood, muscle, nerves and other tissues (Wilgis and Maryland, 1971; Hagenouw et al., 1986; 
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Benzon et al., 1988; Hirst et al., 1990; Maclver and Taneilian, 1992; Crews et al., 1994; Estebe et al., 2000). 
During constant stimulation in response to an ischemic sensation, the large peripheral fibers (A-fibers) failed 
to conduct and the C-fiber firing was maintained (Melzack and Wall, 1965). 
We also applied cold pressor pain (CPP) (2-4 °C) to the right hand (innervated by C5-Th1) 
according to our previous study (Arendt-Nielsen et al., 2008). CPP is a blended sensation evoked by activity 
in more than one type of afferent, including cold-specific channels (Mackenzie et al., 1975), high threshold 
cold receptors (LaMotte and Thalhammer, 1982), Aδ cutaneous (Georgopoulos, 1976,1977; LaMotte and 
Thalhammer, 1982; Simone et al., 1995) and vascular nociceptors (Fruhstorfer and Lindblom, 1983; Arndt 
and Klement, 1991; Klement and Arndt, 1992; Arndt et al., 1993), plus cutaneous (Bessou and Perl, 1969; 
Torebjörk and Hallin, 1974) and perivascular C-nociceptors (Campero et al., 1996). 
 
  
 
Figure 6. The computer-controlled cuff algometry. 
Electronic visual analogue scale is shown on the right side. 
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3.2. Effects of CPM 
3.2.1. Intensity effects of CS 
 The effects of CPM are known to differ, depending on the magnitude and nature of the CS and the 
stimulated nerve fibers (Willer et al., 1984; Villanueva and Le Bars, 1985; Villanueva et al., 1989). 
Willer et al. (1984) demonstrated in healthy volunteers that the spinal nociceptive flexion reflex 
(RIII reflex) elicited by right sural nerve stimulation was inhibited by the immersion of the left hand into a 
heated thermoregulated water bath at the nociceptive temperature, i.e. higher conditioning temperatures 
induced a more intense CPM effect, while non-nociceptive temperatures (40 to 44°C) were without CPM 
effect. In addition, they showed a highly significant linear relationship between the increase in these 
thresholds and the intensity of the CS in the 44 to 47.5°C range. Moreover, the data indicated that, whether 
induced by heat, cold (6°C), mechanical (painful pinch) or chemical (muscular exercise under ischemia) 
procedures, a painful CS strongly depresses, at spinal level, the nociceptive messages elicited from remote 
localized body areas. These intensity-dependent CPM effects have been reported by many researchers in the 
spinal region (Willer et al., 1989; Le Bars et al., 1992; Le Bars, 2002; Granot et al., 2008; 
Tousignant-Laflamme et al., 2008). However, they have not been reported in the craniofacial region in 
humans. 
Table 1 is the raw data from study I, and Fig. 7 is the overall effect of relative PPT changes (A) and 
PPTol changes (B). In study I, the intensity-dependent CPM effect (VAS0: 3.3 ± 1.6%, VAS1: 2.5 ± 2.1%, 
VAS3: 11.8 ± 2.0%, VAS5: 32.6 ± 3.3% for PPT and VAS0: -2.2 ± 2.5%, VAS1: -4.8 ± 2.2%, VAS3: 4.3 ± 
2.4%, VAS5: 11.2 ± 2.8% for PPTol) was systematically shown in the craniofacial region in healthy humans. 
The finding supports the previous reports in the spinal region in humans and in the trigeminal region in 
animals (Willer et al., 1984; Le Bars and Willer, 2002). 
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Figure 7. Relative changes of the pressure pain thresholds (PPT) values (A) and pressure pain tolerance 
thresholds (PPTol) values (B) (%, mean ± standard errors of mean) in the four sessions (target intensity of 
conditioning stimulus (CS); VAS0, VAS1, VAS3 or VAS5) from all the subjects (n = 40; men = 20, women 
= 20). 
The increases are the mean values for two assessment sites (masseter and forearm). *Indicates a significant 
increase of normalized PPT values with CS of VAS5 compared to all other intensities of the CS during the 
application of CS (P < 0.001), and indicates a significant increase of normalized PPTol values with CS of 
VAS5 compared to VAS 0 and VAS1 during the application of CS (P < 0.001) (overall effect from four-way 
ANOVA and post-hoc tests) (from study I). 
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3.2.2. Assessment site effects on CPM 
For the CPM effect there is no consensus concerning the distance between the TS and CS, that is CS 
localization and its efficacy in attenuating the perceived intensity of the TS. According to Le Bars et al. 
(1989) the distance between the TS and CS is not a critical factor for the strength of the inhibition. Daniziger 
et al. (1998) reported that the application of noxious conditioning electrical stimuli, whether segmentally or 
extrasegmentally, produced powerful and long-lasting inhibitory effects, especially with the extrasegmental 
paradigm. 
Contrary to these reports, Defrin et al. (2010) revealed that CPM cannot occur at a small separation 
distance, but it occurs and is stronger at larger separation distances. They conclude that the CPM is affected 
by the distance between two noxious stimuli. 
According to our study with CS to the craniofacial region (innervated by V1, V3 and C2) (study I), 
there were no significant differences in the magnitude of CPM even though the TS were applied to the 
segmental (masseter muscle, innervated by V3) or extrasegmental (forearm, innervated by C5-Th1) region to 
the CS. These observations implicate that the magnitude of CPM is not affected, even if the CS is applied 
segmentally instead of extrasegmentally. This was furthermore supported by the correlations between relative 
changes (increases) in PPT values at both the forearm and masseter muscle and the perceived intensity of the 
CS. These findings are consistent with the previous report (Le Bars et al. 1989, Danziger et al., 1998). 
However, in study III, the magnitude of CPM was bigger in the recording from TA (innervated by L4-S1) 
compared to the recordings from masseter (innervated by V3) and forearm (innervated by C5-Th1) when it 
was assessed with PPT as the TS and was evoked by the CS applied to the right hand (innervated by C5-Th1), 
right upper arm (innervated by C5-Th2) and craniofacial region (innervated by V1, V3, C2). The differences 
in the CPM effects among the assessment sites might partly be related to the method of evaluation (the 
hand-held or computer-controlled algometer) but also the size of the muscle could influence the response. 
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3.2.3. Gender effects on CPM 
Gender differences in pain perception have been well established. In most studies, women report 
more intense pain, more frequent pain and pain of longer duration than men (Unruh, 1996). Greater pain 
sensitivity in women compared to men occurs in the peripheral actions of glutamate (Cairns et al., 2001) and 
morphine (Sessle, 2000), suggesting that peripherally based physiological mechanisms may contribute to the 
gender differences in the pain conditions (Cairns et al., 2001; Sessle, 2005). 
The gender differences in CPM effects are still controversial. According to the recent review 
(Popescu et al., 2010) the majority of the studies using pain report find significantly more efficient CPM in 
men than women (mean women/men ratio = 0.54). They conclude that gender differences in the CPM effect 
depend on both the experimental methodology and the modes of measurement of the effect. 
Moreover, hormonal influence on the CPM has been suggested. In other words the CPM effects of 
women differ with menstrual phase (Tousignant-Laflamme et al., 2008; Tousignant-Laflamme and Marchand, 
2009). In addition, the menstrual phase may also influence the pain response with lower pain threshold 
during the luteal phase compared with the follicular phase (Hapidou and De Catanzaro, 1988). 
In our studies (studies I and II) there were no gender differences in CPM in agreement with other 
previous studies (France and Suchowiecki, 1999; Baad-Hansen et al., 2005; Pud et al., 2005; Quiton and 
Greenspan, 2007; Tousignant-Laflamme et al., 2008; Wang et al., 2010). Though the data on the menstrual 
cycle in women were not recorded in our studies, hormonal influences on CPM could possibly contribute to 
the overall gender differences in pain perception, as well as the CPM evaluation with muscle pain, viz. 
significantly lower PPT and PPTol values in women which were also demonstrated in our studies (studies I 
and II) and in a previous study (Arendt-Nielsen et al., 2008). 
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3.3. Variation in CPM 
To date not many studies have focused on the variation in CPM. A previous study (Granot et al., 
2008) mentioned that the CPM effect is relatively free of individual variability. To our knowledge study III is 
the first investigation to evaluate the CPM effects comparing three different CS modalities together with 
several assessment sites. 
Two factors affect variance in CPM; the factor from methodological matters and the factor from 
individual differences. Concerning individual factors, the inter-individual variation and the intra-individual 
variation should be considered. 
To evaluate the inter-individual variation, the inter-individual coefficient of variation (inter-CV) was 
calculated as standard deviation/mean × 100 (%). For evaluation of the intra-individual variation, the 
intra-individual coefficient of variation (intra-CV) was calculated as intra-CV =   2 / 2d n   /x × 100 
(%), in which d is the difference between two results obtained from one subject, n is the number of subjects, 
and x is the mean of the results obtained from all the subjects (Spetalen et al., 2004). 
 
3.3.1. Methodological factors 
Immersion of the body part in cold water produces arterial pressor responses (Weise et al., 1993). 
Besides, an inverse relationship between blood pressure levels and pain intensity has been demonstrated by 
CPP (Duschek et al., 2007). From that point of view, hot water seems to be a more appropriate model for 
tonic pain compared to CPP (Streff et al., 2010). On the other hand, CPP, ischemic pain and mechanical 
pressure have excellent reliability and validity as well as thermal pain (Edens and Gil, 1995). 
A recent review highlights the methodological variation in inducing CPM effects between different 
studies (Pud et al., 2009), and the approximated CPM effect in numerous studies is 29%. However, it is also 
pointed out that the difference in pain parameters should be taken into account and there is a limit of 
generalization of conclusions from one study to another. Concerning TS, the review (Pud et al., 2009) reports 
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that the approximated median magnitude of the CPM effect measured by the suprathreshold test-pain 
reduction was 29% (ranging from 10% to 55%); the increase in the test-pain thresholds was 25% (ranging 
from 3% to 100%); and the change in the neurophysiological measures was 28.5% (ranging from 10% to 
60%). They suggest that due to the high variation in the studies which measured the changes by test-pain 
thresholds, continued use of test-pain thresholds in future studies may be questionable. 
Table 2 shows the CPM effect in this project (studies I, II and III). In our project, the averaged CPM 
effect from all the data (with CS of VAS5 in study I and without electrical TMJ stimulation in study II) was 
27.1%, which is almost equal to the value in the literature (Pud et al., 2009). Regarding the modalities of TS, 
the CPM effect measured by the increase in the test-pain thresholds (PPT) was 33.5% (ranging from 10.1% 
to 66.3%); the increase in the test-pain tolerance thresholds (PPTol) was 19.5% (ranging from 7.7% to 
32.6%); and the reduction in the pain intensity (VAS) was 30.7% (ranging from 21.3% to 41.5%). 
Undoubtedly, the factor from PPT testing is notable for the variance in CPM. However, previous 
studies reported that the test-retest reliability of the PPT technique can be guaranteed (Cathcart and Pritchard, 
2006; Cathcart et al., 2009). Furthermore, the inter-individual CV for PPT measured by a hand-held 
algometer was 28% for women and 33% for men, and the intra-individual CV based on repeated PPT 
measurements with a 1 week interval was 14% (Brennum et al, 1989). From our investigation, the range of 
the CPM effect with test-pain thresholds (10.1-66.3%) was similar to the values derived from 
neurophysiolological measurement (10-60%) in the above-mentioned review (Pud et al., 2009). Therefore, 
we believe that PPT is reliable and useful to evaluate the CPM effect. 
Study III demonstrated that the CPP caused the significantly strongest CPM effect (43.6 ± 6.2%) 
compared to the tourniquet (31.0 ± 3.7%) and headband (20.5 ± 3.4%) in PPT. Concerning VAS1.6, the 
CPM effect with CPP (37.2 ± 4.4%) was larger than with tourniquet (33.2 ± 5.4%) and headband (21.3 ± 
3.2%). 
From the point of view of the assessment sites, CPM effect recorded from TA was significantly 
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larger (46.6 ± 4.7%) compared to the masseter (17.8 ± 2.2%) and forearm (15.3 ± 2.0%) in PPT. 
Overall, the CPM induced by CPP elicits the strongest responses (43.6%), and the leg as the 
assessment site results in the largest responses when assessed by pressure pain thresholds. 
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3.3.2. Inter-individual variation in CPM 
Our investigation (study III) showed that in general the CPP causes a smaller inter-CV (41.4-60.1%) 
than the tourniquet and headband. 
Gender differences (Ge et al., 2004) and age differences (Washington et al., 2000; Edwards et al., 
2003) could affect CPM responses. Only one article has reported the test-retest reliability of CPM with 
intraclass correlations (ICCs) and coefficient of repeatability (CR) using occlusion cuff (CS) in humans, and 
it concludes that there are no significant differences in the CPM effect across test-retest occasions (Cathcart 
et al., 2009). However, the cuff resulted in a large inter-individual variation (CR was 1.69), which is 
consistent with our result that in general the cuff has larger inter-individual variation than CPP. 
 
3.3.3. Intra-individual variation in CPM 
The possible influential factor on the intra-individual variation in CPM is habituation (Treister et al., 
2010). To minimize the intra-individual variation, it is better to evaluate CPM with the same examiner 
(Antonaci et al., 1998). 
Our experiment (study III) was performed by the same examiner. The smallest threshold variability 
was obtained from the assessment sites at the masseter or the forearm regardless of the CS (35.2-40.1%). For 
pain ratings, the smallest intra-individual variability was obtained with CPP (27.0%). There was a general 
pattern that the CPP leads to smaller intra-CV (27.0-42.4%). 
 
3.3.4. Clinical implications 
Impairments of CPM in chronic pain conditions, such as fibromyalgia (Kosek and Hansson, 1997; 
Lautenbacher and Rollman, 1997), irritable bowel syndrome (Wilder-Smith et al., 2004), migraine (Sandrini 
et al., 2006) and CTTH (Pielsticker et al., 2005), have been reported. It can be speculated that the ongoing 
chronic pain may “exhaust” CPM, leading to dysfunction of CPM or causing an increased facilitation 
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through the descending pathways. An alternative explanation for the relation between chronic pain and 
impairment of CPM is that less efficient CPM might be a risk factor for acquisition of chronic pain in these 
patients. To support the latter option, recent research (Yarnitsky et al., 2008) shows that the pre-operative 
evaluation of CPM may identify patients at the risk of developing chronic pain. For further application of 
CPM as a diagnostic tool or for screening of analgesic compounds the test-retest reliability and 
inter-individual variation in CPM should be determined. 
From the findings of study III, the experimental paradigm with the CPP as the CS and PPT as the TS 
is the most reliable to evaluate CPM. 
 
3.4. Central mechanism of CPM 
As mentioned in the introduction, CPM, formerly termed DNIC, is the phenomenon whereby the 
activities of nociceptive (WDR and NS) neurons are powerfully inhibited by the application of noxious CS to 
any body areas distant from their excitatory receptive fields (Le Bars, 2002). This inhibition is triggered by 
noxious stimuli and affects nociceptive neurons within the spinal cord and the trigeminal system (Villanueva 
and Le Bars, 1985; Hu, 1990; Le Bars et al., 1995; Meng et al., 1997). 
CPM is a spinal-supraspinal feedback loop which modulates spinal neuronal activity (Le Bars et al., 
1995). A painful stimulation to a region of the body activates spinal dorsal horn neurons or neurons in the 
trigeminal spinal tract nucleus and sends an excitatory signal (through the ventrolateral quadrant for spinal 
dorsal horn neurons) towards higher centers, including the lower brainstem, especially SRD (within the 
caudal-most aspect of the medulla). This signal activates CPM, which inhibits spinal and trigeminal 
nociceptive neurons through the dorsolateral funiculi (Le Bars et al., 1995, Le Bars and Willer, 2002). 
According to the review (Villanueva et al., 1996), the SRD plays a specific role in processing 
cutaneous and visceral nociceptive inputs, particularly in CPM. From a general point of view, the reciprocal 
connections between the caudal medulla and spinal cord suggest that this area is an important link in the 
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feedback loops which regulate spinal outflow. Moreover, the existence of SRD-thalamic connections put a 
new light on the role of spino-reticulo-thalamic circuits in pain transmission. 
Taken together, the inhibitions are mediated by a spino-bulbo-spinal loop, the ascending part of 
which is composed of the spinoreticular tract and synaptic relays in the brainstem (Le Bars and Willer, 2002). 
Concerning the endogenous mechanism of CPM, CPM - whether tested on WDR neurons in animals 
or the nociceptive RIII reflex in man - is blocked by naloxone (Le Bars et al., 1981; Willer et al., 1990). This 
fact implies that there is at least one opioidergic link in this loop both in the rat and in man (Le Bars et al., 
1981; Willer et al., 1990). 
Recent animal studies have also shown that systemic or local (close to the nucleus raphe magnus: 
RMg) administration of an α1-adrenoceptor agonist, phenylephrine (PE), and systemic administration of a 
selective α2-adrenoceptor agonist, dexmedetomidine (DEX), inhibit DNIC (Sanada et al., 2009; Makino et al., 
2010). These findings suggest that adrenergic neurons are involved in DNIC. 
 
3.4.1. CPM in healthy humans 
Following animal DNIC studies, CPM has been focused on healthy humans. Price and McHaffie 
(1988) observed that the pain elicited by intense electrical stimulation of the ankle area was decreased by 
noxious thermal CS of the skin of either the dorsal surface of the contralateral foot or the abdominal region. 
Roby-Brami et al. (1987) reported that the RIII reflex was inhibited by nociceptive electrical stimuli applied 
to the fingers. Terkelsen et al. (2001) showed CPM as the inhibition of the nociceptive withdrawal reflex by 
CPP. 
CPM is activated by conditioning stimulus. In addition, CPM is also affected by psychological 
factors, such as attention and distraction (Fernandez and Turk, 1989; Quiton and Greenspan, 2007; Defrin et 
al., 2010). Both distraction and stress can reduce pain (Fernandez and Turk, 1989) and contribute to 
pain-evoked hypoalgesia. Also factors such as task difficulty and the environmental demands (emotional 
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arousal) are implicated in moderating the interruptive function of pain (Eccleston and Crombez, 1999). 
 
3.4.2. CPM in craniofacial region 
 Animal studies demonstrate that the trigeminal subnuclei caudalis and oralis are involved in the 
DNIC effect (Dickenson et al., 1980; Dallel et al., 1990; Hu, 1990). Subsequently, the CPM effect in the 
craniofacial region has been reported in humans (Svensson et al., 1999a,b; Mason et al., 2007; Oono et al., 
2008). Ellrich and Treede (1998) reported that the blink reflex caused by electrical stimulation of the 
supraorbital nerve was reduced when heat stimulation was administered to the ipsilateral or contralateral 
forearm or the ipsilateral foot bottom. 
From study I it is systematically demonstrated in healthy humans that CPM is triggered in the 
craniofacial region by the application of mechanical stimulus. 
The nociceptive input from the mechanical headband would result in the activation of the 
corresponding segmental pools of both NS and WDR neurons in the trigeminal subnucleus caudalis. These 
signals might reach the other brain centers involving the caudal-most part of the medulla, including the SRD, 
and could access descending pathways in the dorsolateral funiculi (Le Bars, 2002). Accordingly, CPM may 
cause inhibition of activity in nociceptive neurons in the trigeminal subnucleus caudalis (Hu, 1990; 
Raboisson et al., 1995) or the spinal dorsal horn (Le Bars et al., 1979a) to the same degree corresponding to 
the intensity of the CS, that is, the CPM effect in a CS intensity dependent manner without assessment site 
difference (segmental: craniofacial / extrasegmental: spinal). 
Overall, we report here, for the first time, that the CPM effect in the craniofacial region in humans is 
CS intensity dependent consistent with a previous animal report (Bouhassira et al., 1987) but not assessment 
site or gender dependent. 
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3.5. Modulation of CPM by experimental TMJ pain 
3.5.1. Influence of experimental pain on CPM 
 According to the report from Arendt-Nielsen et al. (2008), the two concomitantly applied CS (CPP 
to the hand and muscle pain to the TA) evoke less CPM despite higher perceived pain intensity by the 
subjects. 
On the other hand, in study II, the concomitantly evoked pain (mechanical craniofacial pain and 
electrical TMJ pain) did not impair CPM effects (Table 3, Fig. 8). The differences in the methodological 
matters (the assessment site for TS, the stimulated site for CS and the nature of the CS) might affect these 
inconsistent results. 
Interestingly, in study II, the TMJ pain values (VAS-TMJ, painful) tended to decrease during the 
application of CS (Fig. 9). This observation suggests that the CS triggered the CPM effects on both the TS 
and the TMJ stimulation. Moreover, the CS pain values in the painful session (VAS-CS, painful: VAS-TMJ 
= 5) were significantly lower than in the control session (VAS-CS, control: VAS-TMJ = 0, only with 
insertion of the needle electrodes and without electrical stimulation). This fact also implies that the painful 
TMJ stimulation triggered a CPM effect on the CS. These phenomena indicate a bidirectional mechanism of 
CPM which, to our knowledge, has not been reported before. 
Higher prevalence of many chronic muscle pain conditions in women has been reported (Cairns et 
al., 2001; Sessle, 2005). In addition, female reproductive hormones may play a role in craniofacial pain 
(LeResche et al., 1997). 
Meanwhile, there were no gender differences in the CPM effect in our investigation (study II). The 
fact that the data on the menstrual cycle in women were not recorded in study II might affect these 
differences. The information on the menstrual cycle would be valuable for elucidation of gender differences 
in future studies. 
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Figure 8. Relative values of the pressure pain thresholds (PPT) (A) and pressure pain tolerance thresholds 
(PPTol) (B) (%, mean ± standard errors of mean) in the control (without electrical TMJ stimulation) and the 
painful (with electrical TMJ stimulation) sessions from all the subjects (n = 40; men = 20, women = 20). 
The increases are the mean values for two assessment sites (masseter and forearm). “During TMJ 
stimulation” represents “with insertion of the needles” in the control session and “with electrical TMJ 
stimulation” in the painful session. “During CS (conditioning stimulus)” represents “during conditioning and 
TMJ stimulation” and “Imm after the CS” represents “Immediately after the conditioning and TMJ 
stimulation”. *Indicates significant increases of normalized PPT and PPTol values compared with baseline 
values (P < 0.001) in both sessions (overall effect from four-way ANOVA and post-hoc tests). There were no 
significant differences between sessions in the increment of PPT and PPTol during CS (from study II). 
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Figure 9. Continuous visual analogue scale (VAS) ratings of the pain intensity of the repetitive electrical 
temporomandibular joint (TMJ) stimulation in the painful session (VAS-TMJ, painful), the pain intensity of 
the needle electrodes in the control session (VAS-TMJ, control) and the pain intensity of the craniofacial 
compression (conditioning stimulus: CS) (VAS-CS) in two sessions (control: VAS-TMJ = 0, painful: 
VAS-TMJ = 5) from all the subjects (n = 40; men = 20, women = 20) (mean ± standard errors of mean). 
The black arrow shows the needle insertion and the white arrow shows the application of mechanical 
craniofacial pain (CS). In the control session the VAS-TMJ pain values after the needle insertion was low 
(under VAS = 1) and stable. In the painful session the VAS-TMJ pain values tended to decrease during CS. 
The CS pain values in the painful session (VAS-CS, painful) were significantly lower (P = 0.008) than in the 
control session (VAS-CS, control) (from study II). 
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3.5.2. Clinical implications 
Impairments of endogenous pain-modulatory pathways are implicated in clinical pain conditions. 
Study II implies that two experimental painful stimuli may interact in a complex manner like in 
persistent pain conditions where changes in the balance between descending inhibition and facilitation may 
occur. 
Study II also showed that acute experimental TMJ pain did not alter CPM effects evoked by tonic 
painful mechanical stimulation of the craniofacial region. Deficiencies in CPM effects in persistent pain 
conditions are therefore most likely more related to the duration of the clinical pain than the pain per se. 
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4. CONCLUSIONS AND PERSPECTIVES 
The aims and conclusions from this project are shown in Fig. 10. 
The conclusions from this project are: 
1. The CPM effect in the craniofacial region is intensity dependent but not assessment site 
(segmental: craniofacial / extrasegmental: spinal) or gender dependent (study I). 
2. The acute experimental TMJ pain does not alter the magnitude of the CPM effects in either 
gender, that is, deficiencies in CPM in persistent pain conditions are most likely more related 
to the duration of clinical pain than the pain per se (study II). 
3. The cold pressor pain evokes the largest CPM, the leg as the assessment site results in the 
largest CPM responses, and the cold pressor pain causes the smallest inter- and 
intra-individual variation. The result implicates that the cold pressor pain is the most efficient 
conditioning stimulus to induce CPM when assessed by pressure pain thresholds (study III). 
The present project showed that the mechanical compressive device and the experimental TMJ pain 
models are suitable for systematic elucidation of the pain-modulatory mechanism in the craniofacial region in 
humans. Moreover, this project provides information on the endogenous pain-modulatory mechanism in 
healthy humans; two experimental painful stimuli interact in a complex manner like in persistent pain 
conditions. 
The general conclusions from this project are; 1) the CPM effect in the craniofacial region is 
dependent on the intensity of the conditioning stimulus without any assessment site or gender differences, 2) 
deficiencies in CPM in persistent pain conditions are most likely more related to the duration of clinical pain 
than the pain per se, and 3) the experimental paradigm with the cold pressor pain as the conditioning stimulus 
and pressure pain thresholds as the test stimulus is the most reliable method to evaluate CPM. 
The clinical relevance of CPM assessments is not examined in this project. Therefore, future 
research on CPM with clinical pain patients would be of major value to elucidate the endogenous 
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pain-modulatory mechanism. Furthermore, it would be useful to explore and develop more reliable method to 
test CPM for experimental and clinical use, to evaluate endogenous pain-modulatory mechanism with CPM 
and to develop new and more efficient analgesic treatments which specifically interact with CPM in chronic 
pain patients. 
Further investigation of the above mentioned studies on CPM will lead to the possible benefit of the 
many millions of people suffering from pain. 
 
 
 
Figure 10. Diagram of the aims and conclusions in this project. 
TMJ: temporomandibular joint, CPM: conditioned pain modulation. 
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5. ENGLISH SUMMARY 
Conditioned pain modulation (CPM) 
: experimental studies in the craniofacial region in healthy humans 
 
This Ph.D. thesis is based on three research studies, which have been carried out in the period from 
2009 to 2011 at Center for Sensory-Motor Interaction (SMI), Department of Health Science and Technology, 
Faculty of Medicine, Aalborg University, Denmark. 
Conditioned pain modulation (CPM) in the craniofacial region in healthy humans has received little 
attention. Moreover, chronic craniofacial musculoskeletal pain conditions such as temporomandibular 
disorders (TMD) are associated with alternations in pain-modulatory processes reflected in CPM. Recent 
research suggests that the evaluation of CPM may identify patients at risk of developing chronic pain. For 
further application of CPM as a diagnostic tool or for screening of analgesic compounds, the test-retest 
reliability and inter-individual variation in CPM need to be studied. 
The aims of this Ph.D. project were to investigate systematically if the CPM is intensity, assessment 
site (segmental: craniofacial region / extrasegmental: spinal region) and gender dependent in the craniofacial 
region (study I); if an ongoing experimental temporomandibular joint (TMJ) pain influences the CPM evoked 
by standardized mechanical craniofacial pain (study II), and to evaluate the inter- and intra-individual 
variation in CPM evoked by the different stimulus modalities (study III). 
 Study I showed for the first time that the CPM effect in the craniofacial region (evoked by 
mechanical stimulation) is intensity dependent but not assessment site (segmental: craniofacial region / 
extrasegmental: spinal region) or gender dependent. Study II indicated that acute experimental TMJ pain 
does not alter the magnitude of the CPM effects in either gender, suggesting that deficiencies in CPM in 
persistent pain conditions are most likely more related to the duration of clinical pain than the pain per se. In 
addition, study III showed that the cold pressor pain (CPP) evokes the largest CPM responses and leads to the 
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smallest inter- and intra-individual variation. The leg as the assessment site results in the largest CPM 
responses. These results implicate that the CPP is the most efficient conditioning stimulus to induce CPM 
when assessed by pressure pain thresholds. 
In conclusion, the present work on CPM has provided new information on the pain modulation 
system. The results might be helpful to improve the knowledge of assessment, diagnosis and treatment of 
TMD and other craniofacial pain disorders. 
- 45 - 
 
6. DANISH SUMMARY 
Betinget smertemodulation (CPM) 
: eksperimentelle studier i den kraniofaciale region hos raske mennesker 
 
Denne Ph.D.-afhandling er baseret på tre forskningsrapporter. Undersøgelserne er gennemført i 
perioden 2009-2011 på Center for Sanse-Motorisk Interaktion (SMI), Det Sundhedsvidenskabelige Fakultet, 
Aalborg Universitet, Danmark. 
Betinget smertemodulation (CPM) i den kraniofaciale region hos raske mennesker er kun undersøgt 
lidt. Desuden er kroniske kraniofaciale muskuloskeletale smertetilstande, som f.eks. temporomandibulær 
dysfunktion (TMD), forbundet med vekslen i smerte-modulerende processer afspejlet i CPM. Nylige 
forskningsresultater har vist, at evalueringen af CPM kan identificere patienter med risiko for at udvikle 
kroniske smerter. For yderligere at kunne anvende CPM som et diagnostisk værktøj eller til screening af 
smertestillende stoffer skal test-retest pålidelighed og inter-individuelle variationer af CPM fastlægges. 
Formålet med nærværende projekt er systematisk at undersøge, om CPM er intensitets-, 
vurderingssteds- (segmentær: kraniofaciale region / ekstra-segmentær: spinale region) og kønsafhængig i den 
kraniofaciale region (studie I); påvirkningen af eksperimentelle kæbeledssmerter på CPM fremkaldt ved 
hjælp af standardiserede mekanisk kraniofacial smerte samt (studie II), at vurdere inter- og intra-individuel 
variation af de forskellige stimuli-metoder til fremkaldelse af CPM (studie III). 
Dette forskningsprojekt har som det første vist, at CPM-effekten i den kraniofaciale region 
(fremkaldt ved hjælp af mekanisk stimulation) er intensitetsafhængig, men ikke vurderingsteds- (segmentær: 
kraniofacial / ekstra-segmentær: spinal) eller kønsafhængig (studie I). Desuden viser forsøget, at akutte 
eksperimentelle kæbeledssmerter ikke ændrer styrken af CPM-effekterne hos nogen af de to køn, det vil sige 
at mangler i CPM i vedvarende smerter sandsynligvis er mere relateret til varigheden af den kliniske smerte 
end smerten i sig selv (studie II). Desuden viste studiet af den inter- og intra-individuel variation i CPM, at 
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kold pressorsmerte (CPP) fremkalder den største CPM, at benet som vurderingssted resulterer i de højeste 
CPM-reaktioner, og at CPP forårsager den mindste inter- og intra-variationskoefficient (CV). Resultatet 
indikerer, at CPP er den mest effektive konditioneringsstimulus til fremkaldelse af CPM, da den blev 
vurderet ved hjælp af tryksmertetærskler (studie III). 
Dette CPM-studie har givet ny information om smertemodulationssystemet. Resultaterne kan være 
nyttige til forbedring af diagnosticering og behandling af kæbeledssmerter samt andre kraniofaciale 
smertelidelser. 
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